Insider Trading History of Main Alan J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Main Alan J since 2011. This trader's CIK number is 1227372. At the time of last reporting, Main Alan J was the EVP, Innov & Chem Sciences of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX). Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..


Yearly summary of insider trading at Lexicon Pharmaceuticals, Inc. (LXRX) by Main Alan J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 LXRX 0 $0 0 $0 126,814 $0
2023 LXRX 0 $0 0 $0 57,943 $0
2022 LXRX 0 $0 0 $0 54,650 $0
2021 LXRX 0 $0 0 $0 56,468 $0
2020 LXRX 0 $0 0 $0 37,252 $0
2019 LXRX 0 $0 0 $0 20,151 $0
2018 LXRX 0 $0 0 $0 14,533 $0
2017 LXRX 0 $0 0 $0 14,391 $0
2016 LXRX 0 $0 0 $0 12,807 $0
2015 LXRX 0 $0 0 $0 69,000 $0
2014 LXRX 0 $0 0 $0 50,250 $0
2013 LXRX 0 $0 0 $0 65,350 $0
2012 LXRX 0 $0 0 $0 16,250 $0
2011 LXRX 0 $0 0 $0 19,211 $21,708


Insider trading of Lexicon Pharmaceuticals, Inc. (LXRX) by Main Alan J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-02-28 LXRX Option Ex 126,814 .00 0
2023-02-28 LXRX Option Ex 57,943 .00 0
2022-02-28 LXRX Option Ex 54,650 .00 0
2021-02-28 LXRX Option Ex 56,468 .00 0
2020-02-28 LXRX Option Ex 37,252 .00 0
2019-02-28 LXRX Option Ex 20,151 .00 0
2018-02-28 LXRX Option Ex 14,533 .00 0
2017-02-28 LXRX Option Ex 14,391 .00 0
2016-02-29 LXRX Option Ex 12,807 .00 0
2015-03-02 LXRX Option Ex 69,000 .00 0
2014-02-28 LXRX Option Ex 50,250 .00 0
2013-02-28 LXRX Option Ex 33,750 .00 0
2013-01-31 LXRX Option Ex 31,600 .00 0
2012-02-28 LXRX Option Ex 16,250 .00 0
2011-12-22 LXRX Option Ex 19,211 1.13 21,708

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Main Alan J (EVP, Innov & Chem Sciences of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.